LGND – ligand pharmaceuticals incorporated (US:NASDAQ)
Stock Stats
News
4/4
11:17 am
lgnd
Low
Is Ligand Pharmaceuticals (LGND) Still Attractive After Doubling Over The Past Year [Yahoo! Finance]
3/30
08:11 pm
lgnd
Medium
CLO Sells LGND 5,000 Shares for $1.0 Million [Yahoo! Finance]
3/30
05:45 am
lgnd
Low
Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes [Yahoo! Finance]
3/27
09:00 pm
lgnd
Low
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know [Yahoo! Finance]
3/26
07:00 am
lgnd
Low
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
2/26/2026
07:00 am
lgnd
1.9%
BEAT
11/6/2025
07:00 am
lgnd
4.6%
BEAT
8/7/2025
07:00 am
lgnd
1.9%
BEAT
5/8/2025
07:00 am
lgnd
-2.5%
BEAT
3/24
11:12 am
Maintains
Buy
Buy
Citigroup
Low
1.7%
3/24
11:12 am
Maintains
Buy
Buy
Citigroup
Low
1.7%
3/11
08:03 am
Initiates
Buy
Bank of America Corporation
Medium
4.7%
2/27
10:44 am
Maintains
Outperform
Outperform
Oppenheimer
Low
0.7%
2/27
10:44 am
Maintains
Outperform
Outperform
Oppenheimer
Low
0.7%
4/2
07:44 pm
lgnd
Low
Form 4 LIGAND PHARMACEUTICALS For: Apr 01 Filed by: KOZARICH JOHN W
4/2
06:57 pm
lgnd
Low
Form 4 LIGAND PHARMACEUTICALS For: Apr 01 Filed by: Reardon Andrew
4/1
04:11 pm
lgnd
Low
Form 144 LIGAND PHARMACEUTICALS Filed by: KOZARICH JOHN W
3/31
05:53 pm
lgnd
Low
Form 4 LIGAND PHARMACEUTICALS For: Mar 06 Filed by: LAMATTINA JOHN L
3/27
09:20 pm
lgnd
Low
Form 4 LIGAND PHARMACEUTICALS For: Mar 02 Filed by: Espinoza Octavio
Show more
Top News Gainers
3/17 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 24.8%
11/8 Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol 7.1%
3/2 Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March 6.5%
9/12 Form 8-K LIGAND PHARMACEUTICALS For: Aug 27 6.3%
4/8 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) had its price target lowered by analysts at HC Wainwright from $237.00 to $229.00. 6.2%
4/6 Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call 5.7%
9/19 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $132.00 price target on the stock, up previously from $110.00. 5.5%
3/24 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating. 5.2%
6/3 Form 8-K LIGAND PHARMACEUTICALS For: May 31 4.3%
7/31 Form 4 LIGAND PHARMACEUTICALS For: Jul 31 Filed by: HIGGINS JOHN L 4.2%
Top News Decliners
3/13 Form 4 LIGAND PHARMACEUTICALS For: Mar 13 Filed by: FOEHR MATTHEW W -21.8%
7/30 Q2/2019 6/30/2019 EPS 0.680 ZacksConsensus 0.380 ActVsEst 0.300 - Beat -12.6%
2/27 Form 4 LIGAND PHARMACEUTICALS For: Feb 27 Filed by: FOEHR MATTHEW W -9.5%
11/6 Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.6%
3/27 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -7.2%
8/5 Ligand Pharmaceuticals Inc. (NASDAQ: LGND) had its price target lowered by analysts at Barclays PLC from $131.00 to $110.00. They now have an "equal weight" rating on the stock. -6.8%
3/10 Ligand Pharmaceuticals (LGND) Presents At Barclays Global Healthcare Conference - Slideshow [Seeking Alpha] -6.4%
6/10 Form 8-K LIGAND PHARMACEUTICALS For: Jun 06 -4.7%
11/13 Form 4 LIGAND PHARMACEUTICALS For: Nov 12 Filed by: FOEHR MATTHEW W -4.7%
3/17 Ligand Pharmaceuticals (LGND) Presents At 32nd Annual ROTH Conference - Slideshow [Seeking Alpha] -4.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3